Ypsomed Digital Health
Managing their own disease treatment is complex for many patients. Different treatment regimes, misinformation about the condition, and emotional distress with self-injection are only some of the factors that lead to poor therapy adherence and diminished treatment effectiveness.
We strongly believe that multifactorial support is needed to aid patients in managing their chronic condition.
We provide pharmaceutical companies with integrated digital solutions by combining connected injection devices with digital patient solutions. Ypsomed Digital Health helps facilitate therapy management for patients and generates business-changing insights for pharmaceutical companies.
Stay connected with us
Contact us to find out more on how our services can enhance your business. Start your Ypsomed journey today.
Stay up to date on our recent news and publications here.
Burgdorf – Ypsomed (SIX: YPSN) will expand its offering of digital health solutions together with S3 Connected Health in the future. S3 Connected Health, headquartered in Dublin, Ireland is a specialist digital health partner for life science companies.
Ypsomed partners with leading digital therapeutics innovator Sidekick Health to improve therapy outcomes
Burgdorf – Ypsomed (SIX: YPSN) and Sidekick Health today announced a collaboration to extend Ypsomed’s device and SmartServices offering by implementing a self-injection module in Sidekick’s proven digital therapeutics solution.